Table 3.
National age- and sex-specific live discharge incidence rates of TSCI in Canada for 2019.
| Age, years | Male | Female | Total |
|---|---|---|---|
| 0–4 | 2.0 | 2.3 | 2.2 |
| 5–9 | 3.9 | 0.7 | 2.4 |
| 10–14 | 6.6 | 4.9 | 5.7 |
| 15–19 | 33.5 | 13.8 | 23.9 |
| 20–24 | 38.1 | 11.8 | 25.5 |
| 25–29 | 37.9 | 8.8 | 23.8 |
| 30–34 | 33.6 | 8.1 | 21.0 |
| 35–39 | 32.0 | 7.9 | 19.9 |
| 40–44 | 40.5 | 12.0 | 26.1 |
| 45–49 | 47.8 | 9.3 | 28.4 |
| 50–54 | 46.4 | 14.6 | 30.4 |
| 55–59 | 61.6 | 16.8 | 39.1 |
| 60–64 | 58.9 | 17.6 | 37.9 |
| 65–69 | 68.8 | 24.6 | 46.1 |
| 70–74 | 71.8 | 28.3 | 49.2 |
| 75–79 | 82.3 | 56.0 | 68.3 |
| 80–84 | 88.4 | 57.2 | 71.0 |
| 85–89 | 97.3 | 43.4 | 65.0 |
| 90+ | 67.7 | 32.8 | 43.5 |
| Total | 42.1 | 15.3 | 28.6 |
Incidence rates are shown as cases per million per population.